Esbriet (Pirfenidone)

Esbriet (Pirfenidone) is an innovative medication designed for patients suffering from idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring of the lungs. This treatment plays a crucial role in slowing down the decline in lung function associated with IPF, ultimately helping to improve the quality of life for those affected.

Here are some key highlights of Esbriet:

• Mechanism of Action: Esbriet works by modulating the biological processes that contribute to lung fibrosis. It reduces the production of fibrotic tissue in the lungs, which helps to preserve lung function.


• Clinical Efficacy: Clinical trials have demonstrated that Esbriet significantly slows the progression of IPF compared to placebo, providing hope for patients and their families.


• Administration: Esbriet is available in capsule form and is typically taken three times a day with food, ensuring optimal absorption and minimizing gastrointestinal side effects.


• Side Effects: Common side effects include nausea, diarrhea, fatigue, and rash. Patients should be monitored regularly to manage any adverse effects effectively.


• Patient Support: Esbriet is often accompanied by patient support programs to help individuals navigate their treatment journey, including educational resources and assistance with medication adherence.


• Considerations: It is essential for patients to discuss their complete medical history with their healthcare provider before starting Esbriet to ensure it is the right choice for their condition.

Overall, Esbriet represents a significant advancement in the treatment of idiopathic pulmonary fibrosis, offering patients a chance to manage their condition more effectively and maintain a better quality of life.

• Pirfenidone


• Gelatin


• Microcrystalline cellulose


• Magnesium stearate


• Silica, colloidal anhydrous

Esbriet (Pirfenidone) is a medication used to treat idiopathic pulmonary fibrosis (IPF). It is essential to follow the prescribed dosage and instructions provided by your healthcare provider for optimal results.

Before starting Esbriet, make sure to inform your doctor about any other medications you are taking, as well as any pre-existing health conditions.

1. Starting Dose: Typically, treatment begins with a low dose to help your body adjust. The usual starting dose is 267 mg taken three times a day.


2. Gradual Increase: After the first week, your doctor may increase the dose to 534 mg three times daily. Continue to follow the schedule as directed.


3. Consistency: Take Esbriet with food to enhance absorption and reduce the risk of gastrointestinal side effects. Try to take the medication at the same times each day.


4. Missed Dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take two doses at once to make up for a missed dose.


5. Monitoring: Regular follow-ups with your healthcare provider are necessary to monitor your response to treatment and check for any potential side effects.


6. Side Effects: Be aware of possible side effects, including nausea, diarrhea, and fatigue. Contact your doctor if you experience severe side effects or allergic reactions.


7. Hydration: Stay well-hydrated while taking Esbriet, as it can help minimize some side effects.


8. Discontinuation: Do not stop taking Esbriet without consulting your doctor, as this may worsen your condition.

Always keep your healthcare provider informed about any changes in your condition or any new medications you may start. Adhering to these guidelines will help you manage your treatment effectively.